Your search returned 59 studies. (Get alerts for new studies):
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or
Conditions: Breast Cancer - Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Multipeptide Vaccine for Advanced Breast Cancer
Conditions: Breast Neoplasm - Breast Cancer - Cancer of the Breast - Carcinoma, Ductal
1 Location available
- HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Conditions: Advanced Breast Cancer
1 Location available
- A Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
4 Locations available
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor - Protocol Specific - Breast Cancer - Female
1 Location available
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Skin Metastases - Stage IV Breast Cancer
1 Location available
- Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer
Conditions: Breast Cancer - Stage IV Breast Cancer
1 Location available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Conditions: Breast Neoplasms - Breast Cancer - Breast Tumors - Cancer of the Breast - Neoplasms, Breast - Tumors, Breast
1 Location available
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Tripl
Conditions: Inflammatory Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Triple-negative Breast Cancer
2 Locations available
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Conditions: Breast Cancer - Breast Neoplasm
1 Location available
- Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Conditions: Breast Cancer
1 Location available
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
8 Locations available
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
37 Locations available
- A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Conditions: Breast Neoplasms - Breast Cancer - Cancer of the Breast
3 Locations available
- Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- PD0332991/Paclitaxel in Advanced Breast Cancer
Conditions: Breast Cancer
1 Location available
- Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Conditions: Breast Cancer
14 Locations available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors - Breast Cancer - Inflammatory Breast Cancer - Castleman's Disease - Multiple Myeloma
4 Locations available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Pos
Conditions: Her2 Negative Breast Cancer Patients
21 Locations available
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
6 Locations available
- Efficacy and Safety of Chloroquine in Combination With Taxane or Taxane-like Chemotherapy in the Treatment of Advanced or Metastatic Breast Cancer Pat
Conditions: Breast Neoplasms - Breast Cancer
1 Location available
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Diffuse Optical Spectroscopy Imaging in Monitoring and Predicting Response in Patients With Locally Advanced Breast Cancer Undergoing Chemotherapy Bef
Conditions: Breast Cancer
2 Locations available
- MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Conditions: Breast Cancer
1 Location available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Conditions: Breast Cancer
1 Location available
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Conditions: HER2 Amplified Breast Cancer - Metastatic or Advanced Breast Cancer
3 Locations available
- Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Conditions: Breast Cancer
2 Locations available
- Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
1 Location available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
Conditions: Breast Neoplasms
1 Location available
- Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
Conditions: Advanced or Metastatic Breast Cancer
5 Locations available
- Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Conditions: Breast Cancer
4 Locations available
- AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
Conditions: Breast Cancer - Metastatic Breast Cancer - HER-2 Positive Breast Cancer - ER Positive Breast Cancer
1 Location available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Conditions: Colorectal Cancer - Squamous Cell Head and Neck Cancer - Non-small Cell Lung Cancer - Triple Negative Breast Cancer - Other Tumors With EGFR Dependence
2 Locations available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer
1 Location available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients With Locally Advanced or Metastatic Stage
Conditions: Locally Advanced Breast Cancer - Metastatic (Stage IV) Breast Cancer - Stage III-IV Breast Cancer or Inflammatory
1 Location available
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
9 Locations available
- Akt Inhibitor MK-2206 in Patients With Advanced Breast Cancer Who Have Tumors With a PIK3CA Mutation and/or PTEN Loss
Conditions: Breast Cancer
1 Location available
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
3 Locations available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Excluding Breast Cancer
7 Locations available
- Study of ABT-700 in Subjects With Advanced Solid Tumors
Conditions: Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer).
3 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
|